Citigroup’s DarioHealth DRIO Stock Holding History

Citigroup’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8	Buy	+1	New	+$10	﹤0.01%	5749
2023 Q3	–	Sell	-8	Closed	-$654	–	5703
2023 Q2	$654	Hold	8	–	–	﹤0.01%	5361
2023 Q1	$672	Hold	8	–	–	﹤0.01%	5182
2022 Q4	$698	Hold	8	–	–	﹤0.01%	5462
2022 Q3	$1K	Sell	8 -7	-47%	-$751	﹤0.01%	5622
2022 Q2	$2K	Sell	15 -22	-59%	-$2.58K	﹤0.01%	5874
2022 Q1	$4K	Sell	37 -1,391	-97%	-$230K	﹤0.01%	5882
2021 Q4	$370K	Buy	1,428 +1,343	+1,580%	+$408K	﹤0.01%	3992
2021 Q3	$23K	Buy	85 +48	+130%	+$13.8K	﹤0.01%	5167
2021 Q2	$16K	Buy	+37	New	+$14.1K	﹤0.01%	5418

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VGA

Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup's DRIO Position: Q1 2026 in Review

Citigroup opened a new position in DarioHealth (DRIO) in Q1 2026: 1 share worth $8. The stake represents ﹤0.01% of the portfolio and ranks #5749 among its holdings. This is a return to the name: Citigroup previously reported a position in DRIO as recently as Q2 2023.

Citigroup first reported a position in DRIO in Q2 2021 and has held it in 10 quarters since. The position peaked at $370K in Q4 2021. 21 funds tracked by Wall St. Rank hold DRIO as of Q1 2026.

Citigroup held 1 share of DarioHealth worth $8 as of Q1 2026.
DarioHealth was a new Citigroup position in Q1 2026.
DarioHealth made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5749 holding.
Citigroup first reported a position in DarioHealth in Q2 2021 and has held it in 10 quarters since.
Citigroup's DarioHealth position peaked at $370K in Q4 2021.
21 funds tracked by Wall St. Rank held DarioHealth as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.